Fujifilm Diosynth Biotechnologies Texas LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Fujifilm Diosynth Biotechnologies Texas LLC
HHS agencies look to build on COVID-19 experience by developing quicker public/private responses to pandemics and supply chain threats.
Federal agency seeks dialogue with industry on how to enable surge capacity for pandemic vaccines without cutting back on other production.One key factor: workforce development.
BARDA terminates CIADM contract in wake of vaccine cross-contamination incident, begins discussion with industry about next steps for rapid pandemic response capabilities.
- Contract Research, Toxicology Testing-CRO
- Gene Therapy, Cell Therapy
- Synthesis Technologies, Production Processes
- Other Names / Subsidiaries
- Kalon Biotherapeutics LLC